Yu He (Arthur)

Yu Yu (Arthur) has a diverse work experience, starting as a Summer Intern at Novartis Vaccines and Diagnostics in 2012. Yu then worked as a Research Scientist at New York Medical College from 2013 to 2017, where they also held roles as a Graduate Research Assistant and Graduate Teaching Assistant. During their time at the college, they also served as the President of the Chinese Students and Scholars Association. Following this, Yu Yu worked at SunTrust Robinson Humphrey as a Biotech Equity Research Associate from 2017 to 2018. Yu then joined Cantor Fitzgerald as an Equity Research Associate in 2018 before transitioning to H.C. Wainwright & Co., LLC as an Equity Research Vice President in 2019, where they are currently employed.

Yu Yu (Arthur) obtained a Bachelor of Science degree in Biology from Wuhan University, where they studied from 2003 to 2007. Yu then pursued a Ph.D. in Microbiology and Immunology at New York Medical College from 2007 to 2013. Additionally, they have obtained certifications including CFA Level II in July 2016 and CFA Level I in July 2014. Yu has also completed the "From Idea to IPO" course from The New York Academy of Sciences. While the obtained month and year for the course completion are not provided, it can be assumed that they completed it at some point in their education history. Furthermore, Yu Yu (Arthur) has certifications in Series 63, Series 7, and Series 87, obtained from FINRA (Financial Industry Regulatory Authority), but the specific months and years of obtaining these certifications are not provided.